CA2619817A1 - Thermodynamically stable polymorph of an azabicyclohexane - Google Patents

Thermodynamically stable polymorph of an azabicyclohexane Download PDF

Info

Publication number
CA2619817A1
CA2619817A1 CA002619817A CA2619817A CA2619817A1 CA 2619817 A1 CA2619817 A1 CA 2619817A1 CA 002619817 A CA002619817 A CA 002619817A CA 2619817 A CA2619817 A CA 2619817A CA 2619817 A1 CA2619817 A1 CA 2619817A1
Authority
CA
Canada
Prior art keywords
polymorph
polymorph form
acid addition
azabicyclo
hexane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002619817A
Other languages
English (en)
French (fr)
Inventor
Eric J. Hagen
Kevin Halloran
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DOV Pharmaceutical Inc
Original Assignee
Euthymics Bioscience Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euthymics Bioscience Inc filed Critical Euthymics Bioscience Inc
Publication of CA2619817A1 publication Critical patent/CA2619817A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
CA002619817A 2004-08-18 2005-08-17 Thermodynamically stable polymorph of an azabicyclohexane Abandoned CA2619817A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US92074804A 2004-08-18 2004-08-18
US10/920,748 2004-08-18
PCT/US2005/029420 WO2006023659A2 (en) 2004-08-18 2005-08-17 Novel polymorphs of azabicyclohexane

Publications (1)

Publication Number Publication Date
CA2619817A1 true CA2619817A1 (en) 2006-03-02

Family

ID=35968183

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002619817A Abandoned CA2619817A1 (en) 2004-08-18 2005-08-17 Thermodynamically stable polymorph of an azabicyclohexane

Country Status (14)

Country Link
EP (1) EP1786417A4 (ru)
JP (1) JP2008510715A (ru)
KR (3) KR20130108489A (ru)
CN (1) CN101052393A (ru)
AU (1) AU2005277351A1 (ru)
BR (1) BRPI0515193A (ru)
CA (1) CA2619817A1 (ru)
IL (1) IL181185A (ru)
MX (1) MX2007001827A (ru)
NO (1) NO20071372L (ru)
NZ (1) NZ589033A (ru)
RU (1) RU2007109817A (ru)
WO (1) WO2006023659A2 (ru)
ZA (1) ZA200701570B (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070043100A1 (en) 2005-08-16 2007-02-22 Hagen Eric J Novel polymorphs of azabicyclohexane
EP2719384B1 (en) 2005-07-27 2018-08-08 Otsuka America Pharmaceutical, Inc. Novel 1-naphthyl-3-azabicyclo[3.1.0]hexanes:preparation and use to treat neuropsychiatric disorders
US20080045725A1 (en) * 2006-04-28 2008-02-21 Murry Jerry A Process For The Synthesis of (+) And (-)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane
US8138377B2 (en) 2006-11-07 2012-03-20 Dov Pharmaceutical, Inc. Arylbicyclo[3.1.0]hexylamines and methods and compositions for their preparation and use
US9133159B2 (en) 2007-06-06 2015-09-15 Neurovance, Inc. 1-heteroaryl-3-azabicyclo[3.1.0]hexanes, methods for their preparation and their use as medicaments
AU2011336318A1 (en) * 2010-12-03 2013-07-04 Euthymics Bioscience, Inc. Preparation and use of (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane in the treatment of conditions affected by monoamine neurotransmitters
EP2994129A4 (en) * 2013-05-07 2017-01-25 Euthymic Bioscience, Inc. Use of (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane to treat addictive and alcohol-related disorders
KR101567003B1 (ko) 2013-12-27 2015-11-06 경희대학교 산학협력단 골편 고정장치 및 골편 절단을 위한 드릴 어셈블리
SI3597189T1 (sl) 2015-06-17 2022-08-31 Otsuka America Pharmaceutical, Inc. Kristalinične spojine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4435419A (en) * 1981-07-01 1984-03-06 American Cyanamid Company Method of treating depression using azabicyclohexanes
US6372919B1 (en) * 2001-01-11 2002-04-16 Dov Pharmaceutical, Inc. (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as an anti-depressant agent

Also Published As

Publication number Publication date
NO20071372L (no) 2007-05-18
EP1786417A4 (en) 2009-05-20
IL181185A0 (en) 2007-07-04
KR20130108489A (ko) 2013-10-02
MX2007001827A (es) 2007-04-23
KR20070054208A (ko) 2007-05-28
CN101052393A (zh) 2007-10-10
RU2007109817A (ru) 2008-09-27
AU2005277351A1 (en) 2006-03-02
WO2006023659A3 (en) 2006-12-07
KR20130004370A (ko) 2013-01-09
JP2008510715A (ja) 2008-04-10
EP1786417A2 (en) 2007-05-23
NZ589033A (en) 2012-06-29
ZA200701570B (en) 2008-08-27
BRPI0515193A (pt) 2008-07-08
WO2006023659A2 (en) 2006-03-02
IL181185A (en) 2012-10-31

Similar Documents

Publication Publication Date Title
US9770436B2 (en) Polymorphs of azabicyclohexane
CA2619817A1 (en) Thermodynamically stable polymorph of an azabicyclohexane
US20070149599A1 (en) Polymorphs of bicifadine hydrochloride
EP1939176A1 (en) Salts of Tegaserod
EP1132390A2 (fr) Diazépino-indoles inhibiteurs de phosphodiestérases 4
KR20070110128A (ko) 퀴누클리딘 유도체의 신규한 염
CN116615424A (zh) 经取代的吡唑并嘧啶的固态形式和其用途
EP2601175A1 (en) A novel crystalline compound comprising saxagliptin and phosphoric acid
JP2010509309A (ja) ３−ベンジル−２−メチル−２，３，３ａ，４，５，６，７，７ａ−オクタヒドロベンゾ［ｄ］イソオキサゾール−４−オンの塩
AU2012203400B2 (en) Novel polymorphs of azabicyclohexane
KR20110095400A (ko) 아자비사이클로－트리플루오로메틸 벤즈아미드 유도체의 신규한 다형태
US7235568B2 (en) 3-(cyclopenten-1-yl)-benzyl-or 3-(cyclopenten-1-yl)-heteroarylmethyl-amine derivatives and use thereof as medicines for treating schizophrenia
NO327100B1 (no) Sitronsyre-salt, farmasoytisk preparat inneholdende slike samt anvendelse av disse for fremstilling av medikament til medisinsk behandling
WO2023225773A1 (en) Solid forms of mesembrine and therapeutic uses thereof
AU2020213989B2 (en) Polymorphic forms of a substituted-quinoxaline-type bridged-piperidine compound
JP5450927B2 (ja) 塩酸テモカプリルのｉ型結晶の製造方法
WO2024079206A1 (en) Polymorphs of (2s,5r)-5-(2-chlorophenyl)-1-(2'-methoxy-[1,1'-biphenyl]-4-carbonyl)pyrrolidine-2-carboxylic acid and preparation processes thereof
EP1713769B1 (en) Amorphous tamsulosin hydrochloride

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued

Effective date: 20180817